Ultragenyx Pharmaceutical stock forecast
Ultragenyx Pharmaceutical (UP0) Stock Forecast & Price Target
UP0 Analyst Ratings
UP0 Stock 12 Month Forecast
Average Price Target
€22.59▲(54.96% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Maxwell Skor | Morgan Stanley | €19.96 | hold | 36.94%Upside | Reiterated | 11/16/26 | ||
| Ram Selvaraju | H.C. Wainwright | €22.68 | buy | 55.62%Upside | Reiterated | 11/06/26 | ||
| Yigal Nochomovitz | Citi | €29.03→€19.96 | buy | 36.94%Upside | Reiterated | 11/06/26 | ||
| Eliana Merle | Barclays | €31.75→€29.03 | buy | 99.19%Upside | Reiterated | 11/05/26 | ||
| Allison Bratzel | Piper Sandler | €32.66 | buy | 124.09%Upside | Reiterated | 11/05/26 | ||
| Joseph Schwartz | Leerink Partners | €29.94 | buy | 105.42%Upside | Reiterated | 11/05/26 | ||
| Tazeen Ahmad | Bank of America Securities | €18.15 | hold | 24.49%Upside | Reiterated | 11/04/26 | ||
| Salveen Richter | Goldman Sachs | €17.24→€15.42 | hold | 5.82%Upside | Reiterated | 11/04/26 | ||
| Whitney Ijem | Canaccord Genuity | €35.38→€30.85 | buy | 111.64%Upside | Reiterated | 11/04/26 | ||
| Laura Chico | Wedbush | €22.68→€19.96 | hold | 36.94%Upside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | €17.24 | hold | 18.27%Upside | Reiterated | 11/04/26 | ||
| Yaron Werber | TD Cowen | €16.33→€17.24 | buy | 18.27%Upside | Reiterated | 11/04/26 | ||
| Benjamin Burnett | Wells Fargo | €16.33→€17.24 | hold | 18.27%Upside | Reiterated | 11/03/26 | ||
| Kristen Kluska | Cantor Fitzgerald | €35.38 | buy | 142.76%Upside | Reiterated | 11/03/26 | ||
| Joon Lee | UBS | €14.52 | hold | -0.40%Downside | Initiated | 10/14/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Maxwell SkorMorgan Stanley | HoldReiterated€19.96 | 11/16/26 | 36.94%Upside | ||
| Ram SelvarajuH.C. Wainwright | BuyReiterated€22.68 | 11/06/26 | 55.62%Upside | ||
| Yigal NochomovitzCiti | BuyReiterated€29.03→€19.96 | 11/06/26 | 36.94%Upside | ||
| Eliana MerleBarclays | BuyReiterated€31.75→€29.03 | 11/05/26 | 99.19%Upside | ||
| Allison BratzelPiper Sandler | BuyReiterated€32.66 | 11/05/26 | 124.09%Upside | ||
| Joseph SchwartzLeerink Partners | BuyReiterated€29.94 | 11/05/26 | 105.42%Upside | ||
| Tazeen AhmadBank of America Securities | HoldReiterated€18.15 | 11/04/26 | 24.49%Upside | ||
| Salveen RichterGoldman Sachs | HoldReiterated€17.24→€15.42 | 11/04/26 | 5.82%Upside | ||
| Whitney IjemCanaccord Genuity | BuyReiterated€35.38→€30.85 | 11/04/26 | 111.64%Upside | ||
| Laura ChicoWedbush | HoldReiterated€22.68→€19.96 | 11/04/26 | 36.94%Upside | ||
| Luca IssiRBC Capital | HoldReiterated€17.24 | 11/04/26 | 18.27%Upside | ||
| Yaron WerberTD Cowen | BuyReiterated€16.33→€17.24 | 11/04/26 | 18.27%Upside | ||
| Benjamin BurnettWells Fargo | HoldReiterated€16.33→€17.24 | 11/03/26 | 18.27%Upside | ||
| Kristen KluskaCantor Fitzgerald | BuyReiterated€35.38 | 11/03/26 | 142.76%Upside | ||
| Joon LeeUBS | HoldInitiated€14.52 | 10/14/26 | -0.40%Downside |
Best Analysts Covering Ultragenyx Pharmaceutical
Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +2.11% per trade.
Copying Whitney Ijem's trades and holding each position for 1 Year would result in 31.58% of your transactions generating a profit, with an average return of -11.18% per trade.
Copying Yaron Werber's trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -25.91% per trade.
UP0 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 24 | 36 | 37 | 22 |
| Buy | 4 | 7 | 8 | 6 | 3 |
| Hold | 4 | 6 | 22 | 22 | 26 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 37 | 66 | 65 | 51 |
In the current month, UP0 has received 25 Buy Ratings, 26 Hold Ratings, and 0 Sell Ratings. UP0 average Analyst price target in the past 3 months is 22.59.
UP0 Financial Forecast
UP0 Earnings Forecast
Next quarter’s earnings estimate for UP0 is EUR 2.16 with a range of EUR 1.89 to EUR 2.68. The previous quarter’s EPS was -EUR 1.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
UP0 Sales Forecast
Next quarter’s sales forecast for UP0 is EUR 204.85M with a range of EUR 184.40M to EUR 216.04M. The previous quarter’s sales results were EUR 156.38M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

